— Know what they know.
/
Not Investment Advice

VREX NASDAQ

Varex Imaging Corporation
1W: +0.3% 1M: +0.0% 3M: +68.6% YTD: +58.5% 1Y: +54.0% 3Y: +3.7% 5Y: -31.8%
$18.46
+0.05 (+0.27%)
Pre-Market: $19.20 (+0.74, +4.01%)
Weekly Expected Move ±0.4%
$18 $18 $18 $18 $19
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 47 · $783.9M mcap · 41M float · 1.83% daily turnover · Short 57% of daily vol
Credit Risk of going bust: higher than 70% of companies Debt: 32.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.87 (down 95%), Varex Imaging Corporation would be worth roughly what it owes.
Total debt $373.6M against a stock market value of $783.9M.
Distance to default 3.40 (Merton model): prices to 2026-10-27, balance sheet 2026-07-03, debt counted $182.7M (short-term plus half of long-term), stock volatility 57.2%; Altman Z 2.28. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
60.9 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 7.6%  ·  5Y Avg: -0.1%
Cost Advantage ★
92
Intangibles
72
Switching Cost
36
Network Effect
35
Scale
68
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. VREX has a Narrow competitive edge (60.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Cost Advantage. ROIC of 7.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$14
Avg Target
$14
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$14.50
Analysts1
Consensus Change History
DateFieldFromTo
2026-08-15 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-02 Jefferies Matthew Taylor $17 $14 -2 +2.3% $14.17
2024-05-28 Jefferies Matthew Taylor Initiated $17 — +14.9% $14.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
3
ROE
2
ROA
3
D/E
1
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. VREX receives an overall rating of B. Strongest factors: P/B (4/5). Areas of concern: ROE (2/5), D/E (1/5).
Rating Change History
DateFromTo
2026-10-26 B- B
2026-10-22 B B-
2026-10-13 B+ B
2026-09-04 B B+
2026-08-24 B+ B
2026-08-14 B B+
2026-08-10 C+ B
2026-05-12 B- C+
2026-05-08 C+ B-
2026-03-06 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 38 Grade C
Profitability
29
Balance Sheet
58
Earnings Quality
61
Growth
60
Value
58
Momentum
65
Safety
50
Cash Flow
9
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. VREX scores highest in Momentum (65/100) and lowest in Cash Flow (9/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.94
Grey Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✗ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
-2.39
Unlikely Manipulator
Ohlson O-Score
-7.72
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB+
Score: 45.6/100
Trend: Improving
Earnings Quality
50/100
OCF/NI: 0.51x
Accruals: 1.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. VREX scores 1.94, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. VREX scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. VREX's score of -2.39 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. VREX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. VREX receives an estimated rating of BB+ (score: 45.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). VREX's score of 50/100 is moderate — some divergence between reported earnings and underlying cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
35.16x
PEG
0.21x
P/S
0.91x
P/B
1.56x
P/FCF
-22.38x
P/OCF
40.00x
EV/EBITDA
7.74x
EV/Revenue
0.84x
EV/EBIT
10.91x
EV/FCF
-35.96x
Earnings Yield
4.89%
FCF Yield
-4.47%
Shareholder Yield
0.33%
Graham Number
$11.66
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 35.2x earnings, VREX commands a growth premium. Graham's intrinsic value formula yields $11.66 per share, 58% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.798
NI / EBT
×
Interest Burden
0.416
EBT / EBIT
×
EBIT Margin
0.077
EBIT / Rev
×
Asset Turnover
0.796
Rev / Assets
×
Equity Multiplier
2.283
Assets / Equity
=
ROE
4.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. VREX's ROE of 4.6% is driven by Asset Turnover (0.796), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$4.41
Price/Value
2.41x
Margin of Safety
-140.61%
Premium
140.61%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with VREX's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. VREX trades at a 141% premium to its adjusted intrinsic value of $4.41, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 35.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$18.46
Median 1Y
$15.45
5th Pctile
$6.64
95th Pctile
$36.03
Ann. Volatility
50.6%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Sunny S. Sanyal
President and Chief Executive Officer
 $815,816 $2,662,978 $4,634,688
Shubham Maheshwari Financial
ancial Officer
 $534,877 $781,974 $1,860,580
Kimberley E. Honeysett
Former SVP, CLO and Corporate Secretary
 $420,908 $479,956 $1,266,317
Andrew J. Hartmann
SVP and General Manager, Detectors
 $494,600 $443,963 $1,256,113
Mark S. Jonaitis
SVP and General Manager, X-Ray Sources
 $405,908 $443,963 $1,184,198

CEO Pay Ratio

83:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,634,688
Avg Employee Cost (SGA/emp): $55,542
Employees: 2,400

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,400
+4.3% YoY
Revenue / Employee
$351,917
Rev: $844,600,000
Profit / Employee
$-29,292
NI: $-70,300,000
SGA / Employee
$55,542
Avg labor cost proxy
R&D / Employee
$37,958
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 3.7% 5.3% 6.2% 5.3% 6.0% 6.4% 5.6% 5.6% 8.8% 8.3% 7.6% 6.1% -8.7% -8.6% -7.5% -25.6% -14.0% -13.3% -16.2% 4.6% 4.64%
ROA 1.5% 2.2% 2.6% 2.2% 2.6% 2.8% 2.4% 2.5% 4.0% 3.7% 3.4% 2.8% -3.9% -3.7% -3.2% -11.4% -6.0% -5.6% -6.8% 2.0% 2.03%
ROIC 5.8% 7.3% 7.3% 6.2% 6.9% 6.8% 6.2% 5.9% 14.2% 14.4% 15.1% 52.4% -37.6% -24.4% -14.4% -4.1% -3.1% -2.5% -3.2% 7.6% 7.61%
ROCE 7.2% 7.9% 9.0% 8.6% 8.0% 7.9% 7.0% 7.0% 5.4% 4.7% 4.1% 2.6% 2.9% 3.0% 4.1% -4.0% -2.6% -2.5% -3.7% 7.3% 7.30%
Gross Margin 33.4% 32.6% 33.0% 34.2% 32.2% 30.8% 31.9% 32.9% 34.3% 30.1% 31.9% 32.0% 32.6% 34.3% 36.0% 33.3% 34.0% 33.3% 33.6% 36.4% 36.44%
Operating Margin 11.7% 7.0% 12.4% 10.7% 10.6% 6.3% 6.8% 10.4% 10.7% 2.2% 3.7% 4.4% 5.3% 5.6% 10.4% -39.8% 8.6% 7.3% 6.7% 10.8% 10.83%
Net Margin 3.8% 0.7% 3.5% 3.8% 5.7% 1.5% 1.8% 3.9% 14.0% -0.3% 0.7% 0.7% -24.3% -0.2% 3.2% -43.9% 5.3% 1.1% -3.8% 7.5% 7.46%
EBITDA Margin 16.0% 10.7% 14.6% 14.4% 13.4% 9.9% 9.9% 14.0% 7.2% 7.3% 8.2% 6.5% 8.2% 8.9% 13.1% -35.0% 12.5% 8.8% 8.2% 13.8% 13.78%
FCF Margin 9.5% 9.7% 7.1% 4.2% -0.5% -2.3% 1.5% 5.9% 9.8% 11.0% 8.5% 5.1% 2.5% 3.1% 4.6% 4.4% 2.2% -1.6% -3.6% -2.3% -2.34%
OCF Margin 11.3% 11.5% 8.8% 5.9% 2.0% 0.3% 4.3% 8.7% 12.1% 13.9% 11.5% 8.2% 5.8% 5.7% 7.3% 7.3% 4.9% 1.9% -0.2% 1.3% 1.31%
ROE 3Y Avg snapshot only -6.26%
ROE 5Y Avg snapshot only -1.64%
ROA 3Y Avg snapshot only -2.53%
ROIC 3Y Avg snapshot only -1.28%
ROIC Economic snapshot only 6.88%
Cash ROA snapshot only 1.03%
Cash ROIC snapshot only 1.47%
CROIC snapshot only -2.62%
NOPAT Margin snapshot only 6.78%
Pretax Margin snapshot only 3.20%
R&D / Revenue snapshot only 10.57%
SGA / Revenue snapshot only 15.41%
SBC / Revenue snapshot only 1.27%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 70.50 54.96 30.31 33.35 28.54 25.76 25.85 40.41 19.69 18.66 17.80 17.74 -10.20 -12.34 -10.09 -2.76 -7.10 -7.28 -5.32 20.45 35.162
P/S Ratio 1.50 1.65 1.06 1.01 1.01 0.95 0.84 1.32 1.06 0.95 0.87 0.73 0.60 0.71 0.51 0.44 0.59 0.58 0.51 0.52 0.906
P/B Ratio 2.54 2.81 1.80 1.68 1.62 1.61 1.42 2.24 1.67 1.46 1.29 1.04 0.91 1.08 0.77 0.80 1.06 1.03 0.93 0.91 1.565
P/FCF 15.83 16.99 14.90 23.80 -196.51 -40.60 56.24 22.29 10.82 8.60 10.30 14.38 23.84 22.72 11.07 10.03 26.55 -37.05 -14.28 -22.38 -22.376
P/OCF 13.25 14.38 11.97 17.14 51.16 343.41 19.39 15.15 8.75 6.80 7.59 8.86 10.28 12.60 7.07 6.12 11.97 30.61 — 40.00 39.999
EV/EBITDA 14.27 14.69 9.88 10.03 10.58 10.64 10.48 14.48 13.37 13.03 12.93 14.66 12.38 14.98 10.50 -70.87 233.09 195.56 -118.17 7.74 7.736
EV/Revenue 1.88 2.01 1.43 1.41 1.41 1.39 1.25 1.72 1.37 1.26 1.20 1.07 0.93 1.19 0.96 0.74 0.88 0.89 0.85 0.84 0.840
EV/EBIT 21.80 21.54 13.85 14.11 14.98 15.00 15.23 20.86 20.97 21.65 22.90 32.62 25.21 27.39 16.38 -17.07 -31.08 -33.16 -22.00 10.91 10.907
EV/FCF 19.89 20.70 20.20 33.11 -275.37 -59.48 83.69 28.88 13.97 11.45 14.20 21.02 37.07 37.79 20.83 16.74 39.68 -57.35 -23.79 -35.96 -35.960
Earnings Yield 1.4% 1.8% 3.3% 3.0% 3.5% 3.9% 3.9% 2.5% 5.1% 5.4% 5.6% 5.6% -9.8% -8.1% -9.9% -36.3% -14.1% -13.7% -18.8% 4.9% 4.89%
FCF Yield 6.3% 5.9% 6.7% 4.2% -0.5% -2.5% 1.8% 4.5% 9.2% 11.6% 9.7% 7.0% 4.2% 4.4% 9.0% 10.0% 3.8% -2.7% -7.0% -4.5% -4.47%
PEG Ratio snapshot only 0.207
Price/Tangible Book snapshot only 1.577
EV/OCF snapshot only 64.282
EV/Gross Profit snapshot only 2.447
Acquirers Multiple snapshot only 10.061
Shareholder Yield snapshot only 0.33%
Graham Number snapshot only $11.66
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 3.33 3.72 3.41 3.44 3.52 3.86 3.93 4.03 4.04 4.30 4.23 3.34 3.32 4.36 4.05 3.51 3.43 3.89 3.20 3.38 3.378
Quick Ratio 1.98 2.07 1.80 1.70 1.77 1.82 1.96 2.15 2.34 2.37 2.37 1.89 1.97 2.50 2.36 1.82 1.83 1.87 1.43 1.53 1.526
Debt/Equity 0.95 0.93 0.87 0.85 0.82 0.91 0.89 0.88 0.83 0.83 0.82 0.81 0.88 1.11 1.09 0.87 0.85 0.83 0.80 0.75 0.752
Net Debt/Equity 0.65 0.61 0.64 0.66 0.65 0.75 0.69 0.66 0.49 0.49 0.49 0.48 0.50 0.72 0.68 0.54 0.52 0.57 0.62 0.55 0.553
Debt/Assets 0.40 0.40 0.38 0.38 0.37 0.39 0.39 0.39 0.38 0.38 0.38 0.38 0.39 0.45 0.44 0.37 0.36 0.36 0.35 0.34 0.340
Debt/EBITDA 4.25 4.00 3.52 3.65 3.81 4.09 4.44 4.42 5.13 5.52 5.93 7.77 7.70 9.24 7.85 -46.15 125.59 101.41 -61.45 3.98 3.979
Net Debt/EBITDA 2.91 2.63 2.59 2.82 3.03 3.38 3.44 3.30 3.01 3.25 3.55 4.63 4.42 5.98 4.92 -28.41 77.12 69.21 -47.21 2.92 2.922
Interest Coverage 1.68 1.88 2.06 2.05 2.02 2.14 2.14 2.39 2.03 1.98 1.69 0.99 1.07 1.12 1.43 -1.01 -0.68 -0.65 -0.79 1.71 1.712
Equity Multiplier 2.37 2.31 2.28 2.26 2.22 2.31 2.29 2.28 2.20 2.18 2.17 2.16 2.27 2.47 2.47 2.36 2.34 2.30 2.30 2.22 2.215
Cash Ratio snapshot only 0.529
Debt Service Coverage snapshot only 2.414
Cash to Debt snapshot only 0.266
FCF to Debt snapshot only -0.054
Defensive Interval snapshot only 396.2 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.72 0.74 0.75 0.74 0.74 0.75 0.75 0.76 0.73 0.72 0.70 0.68 0.66 0.64 0.63 0.71 0.73 0.70 0.70 0.80 0.796
Inventory Turnover 2.20 2.17 2.19 2.10 2.18 2.06 2.05 2.04 2.08 1.95 1.94 1.95 2.04 1.94 1.92 1.87 1.96 1.85 1.80 1.76 1.759
Receivables Turnover 5.86 6.77 5.99 5.58 5.23 6.08 5.59 5.59 5.30 5.90 5.50 5.28 5.05 5.91 5.57 5.68 5.37 6.00 5.84 6.14 6.141
Payables Turnover 8.30 8.03 8.66 7.63 8.41 7.40 7.79 7.74 8.44 7.43 8.06 7.83 8.95 7.93 7.82 7.72 8.59 7.79 6.82 7.37 7.368
DSO 62 54 61 65 70 60 65 65 69 62 66 69 72 62 66 64 68 61 63 59 59.4 days
DIO 166 168 167 174 167 177 178 179 176 188 188 187 179 188 190 196 186 197 202 207 207.5 days
DPO 44 45 42 48 43 49 47 47 43 49 45 47 41 46 47 47 42 47 54 50 49.5 days
Cash Conversion Cycle 184 177 186 192 194 188 196 197 201 200 209 210 210 204 209 213 211 211 211 217 217.4 days
Fixed Asset Turnover snapshot only 5.109
Operating Cycle snapshot only 266.9 days
Cash Velocity snapshot only 8.720
Capital Intensity snapshot only 1.272
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 10.8% 17.4% 17.9% 12.1% 5.0% 3.1% 3.4% 5.0% 4.0% 1.3% -2.7% -7.2% -9.2% -6.5% -3.3% -1.4% 4.1% 4.1% 3.6% 5.3% 5.31%
Net Income 1.3% 1.4% 1.5% 2.5% 74.1% 27.0% -4.0% 13.5% 59.1% 39.4% 47.0% 16.3% -2.0% -2.1% -2.0% -4.9% -47.4% -42.5% -96.9% 1.2% 1.17%
EPS 1.3% 1.4% 1.5% 2.5% 85.2% 37.3% -0.0% -8.8% 28.8% 39.4% 44.5% 42.3% -2.2% -2.1% -1.8% -4.8% -43.9% -38.5% -1.4% 1.2% 1.16%
FCF 8.5% 4.6% 8.6% 1.6% -1.1% -1.2% -78.3% 46.8% 20.9% 5.8% 4.5% -20.8% -76.7% -73.3% -47.1% -13.7% -7.8% -1.5% -1.8% -1.6% -1.55%
EBITDA 26.1% 42.0% 18.3% 84.9% 6.0% -1.1% -15.3% -11.3% -20.0% -25.0% -24.0% -43.1% -33.3% -23.5% -4.4% -1.1% -94.8% -94.0% -1.1% 11.9% 11.92%
Op. Income 3.2% 3.5% 6.2% 1.6% 19.0% 6.3% -17.9% -14.1% -12.6% -21.7% -20.7% -41.2% -58.4% -42.8% -11.4% -1.8% -1.9% -1.6% -1.6% 3.0% 2.98%
OCF Growth snapshot only -81.07%
Asset Growth snapshot only 2.48%
Equity Growth snapshot only 9.07%
Debt Growth snapshot only -5.87%
Shares Change snapshot only 2.65%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 1.9% 2.4% 3.1% 2.9% 3.3% 2.9% 3.4% 5.2% 6.6% 7.1% 5.8% 3.0% -0.3% -0.8% -0.9% -1.3% -0.6% -0.5% -0.8% -1.2% -1.22%
Revenue 5Y — — 40.6% 21.3% 9.7% 3.9% 2.9% 2.7% 2.9% 2.3% 1.9% 1.2% 0.8% 0.6% 0.8% 1.3% 2.7% 3.6% 3.5% 2.6% 2.57%
EPS 3Y -17.6% 4.6% 28.4% 47.7% 23.0% 39.4% 98.0% — — — — — — — — — — — — -3.8% -3.83%
EPS 5Y — — 12.1% -1.0% -7.1% -10.3% -11.3% -11.9% 5.9% 17.0% 25.1% 33.1% — — — — — — — — —
Net Income 3Y -14.2% 9.5% 32.4% 50.5% 25.0% 41.9% 1.0% — — — — — — — — — — — — -9.1% -9.08%
Net Income 5Y — — 14.6% 0.2% -5.7% -9.2% -10.3% -7.0% 11.9% 18.4% 26.8% 35.1% — — — — — — — — —
EBITDA 3Y 5.5% 7.7% 12.7% 16.1% 11.9% 16.3% 17.5% 57.3% — — 1.3% -2.3% -17.3% -17.2% -14.9% — -69.7% -67.5% — -4.1% -4.05%
EBITDA 5Y — — 32.5% 18.4% 4.1% -0.5% -1.6% -1.5% -0.1% -1.5% -1.6% -4.6% -5.7% -2.0% 3.4% — — — — 7.7% 7.70%
Gross Profit 3Y 2.3% 3.4% 5.0% 5.2% 3.4% 3.0% 4.2% 9.8% 15.1% 15.1% 12.8% 3.6% -1.8% -1.3% -0.7% -0.6% 0.8% 1.1% 0.4% 1.2% 1.16%
Gross Profit 5Y — — 37.7% 19.4% 7.8% 1.9% 1.1% 1.0% 2.7% 2.4% 2.4% 1.8% 0.0% 0.8% 2.2% 5.3% 8.8% 9.4% 8.3% 4.3% 4.25%
Op. Income 3Y 18.5% 25.7% 34.0% 35.9% 24.5% 29.8% 41.7% — — — — 9.5% -24.3% -21.9% -16.8% — — — — -2.3% -2.29%
Op. Income 5Y — — 31.6% 18.2% 6.1% 1.9% 0.9% 3.6% 11.6% 10.6% 9.4% 4.9% -6.8% -0.4% 14.8% — — — — 15.8% 15.78%
FCF 3Y 6.1% 22.8% 5.4% -9.6% — — -28.9% 34.5% — — — 45.5% -35.9% -31.8% -14.1% 0.1% — — — — —
FCF 5Y — — 37.9% -0.9% — — -27.8% -0.1% 6.2% 17.1% 7.0% -3.0% -17.1% -12.5% 1.0% 10.7% — — — — —
OCF 3Y 2.8% 13.9% 1.1% -9.3% -38.3% -68.2% -15.5% 17.8% 1.0% — 1.2% 31.4% -20.1% -21.5% -7.3% 5.8% 35.1% 88.6% — -47.6% -47.57%
OCF 5Y — — 40.4% 4.4% -21.1% -52.1% -15.3% -0.8% 4.9% 13.4% 6.2% 0.3% -8.0% -9.1% -0.9% 4.5% 25.9% — — -17.8% -17.85%
Assets 3Y 5.1% 4.4% 5.8% 3.7% 4.4% 3.4% 3.2% 2.6% 3.1% 3.0% 3.4% 2.6% 2.0% 5.4% 5.9% -2.6% -2.2% -2.4% -2.9% -3.2% -3.17%
Assets 5Y — — 10.5% 2.1% 2.6% 3.0% 3.8% 4.4% 4.8% 4.4% 5.3% 3.7% 3.2% 4.5% 4.6% -0.9% -0.6% -0.7% -0.8% -1.1% -1.07%
Equity 3Y 4.3% 4.9% 5.0% 5.8% 6.1% 4.5% 4.8% 4.4% 7.9% 8.1% 8.2% 7.2% 3.5% 3.1% 3.1% -4.0% -4.0% -2.3% -3.0% -2.2% -2.24%
Book Value 3Y 0.0% 0.2% 1.8% 3.9% 4.4% 2.7% 3.2% -4.2% -0.9% 6.8% 7.1% 7.3% 5.7% 5.4% -3.3% -4.8% -4.6% -3.6% -4.1% 3.4% 3.40%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.13 0.05 0.70 0.75 0.85 0.60 0.44 0.55 0.70 0.52 0.49 0.44 0.31 0.27 0.22 0.16 0.32 0.46 0.46 0.27 0.273
Earnings Stability 0.29 0.25 0.14 0.18 0.05 0.04 0.03 0.00 0.10 0.15 0.21 0.52 0.00 0.00 0.01 0.11 0.06 0.06 0.11 0.05 0.051
Margin Stability 0.88 0.89 0.88 0.91 0.88 0.89 0.90 0.92 0.90 0.91 0.92 0.98 0.98 0.99 0.97 0.93 0.89 0.90 0.91 0.96 0.962
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 1 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.84 0.81 0.93 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.20 0.200
Earnings Smoothness — — — — 0.46 0.76 0.96 0.87 0.54 0.67 0.62 0.85 — — — — — — — — —
ROE Trend 0.08 0.11 0.12 0.09 0.10 0.11 0.09 0.05 0.04 0.02 0.02 0.01 -0.16 -0.16 -0.14 -0.35 -0.15 -0.14 -0.17 0.16 0.161
Gross Margin Trend 0.04 0.04 0.04 0.03 0.04 0.03 0.02 -0.01 -0.01 -0.01 -0.01 -0.00 -0.01 0.00 0.01 0.02 0.02 0.02 0.00 0.01 0.012
FCF Margin Trend 0.07 0.08 0.05 0.02 -0.05 -0.06 -0.02 0.03 0.05 0.07 0.04 -0.00 -0.02 -0.01 -0.00 -0.01 -0.04 -0.09 -0.10 -0.07 -0.071
Sustainable Growth Rate 3.7% 5.3% 6.2% 5.3% 6.0% 6.4% 5.6% 5.6% 8.8% 8.3% 7.6% 6.1% — — — — — — — 4.6% 4.64%
Internal Growth Rate 1.5% 2.3% 2.7% 2.3% 2.7% 2.8% 2.5% 2.5% 4.1% 3.8% 3.6% 2.9% — — — — — — — 2.1% 2.08%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 5.32 3.82 2.53 1.95 0.56 0.07 1.33 2.67 2.25 2.74 2.34 2.00 -0.99 -0.98 -1.43 -0.45 -0.59 -0.24 0.02 0.51 0.511
FCF/OCF 0.84 0.85 0.80 0.72 -0.26 -8.46 0.34 0.68 0.81 0.79 0.74 0.62 0.43 0.55 0.64 0.61 0.45 -0.83 15.40 -1.79 -1.788
FCF/Net Income snapshot only -0.914
OCF/EBITDA snapshot only 0.120
CapEx/Revenue 1.8% 1.8% 1.7% 1.7% 2.5% 2.6% 2.8% 2.8% 2.3% 2.9% 3.0% 3.2% 3.3% 2.5% 2.6% 2.8% 2.7% 3.4% 3.4% 3.6% 3.64%
CapEx/Depreciation snapshot only 1.154
Accruals Ratio -0.07 -0.06 -0.04 -0.02 0.01 0.03 -0.01 -0.04 -0.05 -0.06 -0.05 -0.03 -0.08 -0.07 -0.08 -0.17 -0.10 -0.07 -0.07 0.01 0.010
Sloan Accruals snapshot only -0.022
Cash Flow Adequacy snapshot only 0.359
Earnings Quality Score snapshot only 0.500
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — — 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — —
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — — 6.8% 6.79%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.0% 0.3% 0.3% 0.3% 0.33%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% -0.3% -0.0% -0.4% -0.4% -0.40%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% -0.3% -0.0% -0.4% -0.4% -0.40%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.61 0.69 0.63 0.57 0.68 0.69 0.70 0.66 1.54 1.76 2.12 9.77 -9.54 -5.86 -2.53 1.87 1.19 1.17 1.10 0.80 0.798
Interest Burden (EBT/EBIT) 0.40 0.47 0.53 0.53 0.55 0.58 0.57 0.60 0.54 0.49 0.44 0.13 0.17 0.23 0.34 1.98 2.47 2.52 2.26 0.42 0.416
EBIT Margin 0.09 0.09 0.10 0.10 0.09 0.09 0.08 0.08 0.07 0.06 0.05 0.03 0.04 0.04 0.06 -0.04 -0.03 -0.03 -0.04 0.08 0.077
Asset Turnover 0.72 0.74 0.75 0.74 0.74 0.75 0.75 0.76 0.73 0.72 0.70 0.68 0.66 0.64 0.63 0.71 0.73 0.70 0.70 0.80 0.796
Equity Multiplier 2.45 2.41 2.38 2.36 2.29 2.31 2.29 2.27 2.21 2.24 2.23 2.21 2.24 2.32 2.32 2.24 2.31 2.39 2.39 2.28 2.283
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $0.40 $0.57 $0.70 $0.64 $0.74 $0.79 $0.70 $0.58 $0.95 $1.10 $1.02 $0.83 $-1.17 $-1.16 $-0.82 $-3.19 $-1.68 $-1.60 $-1.97 $0.52 $0.52
Book Value/Share $11.11 $11.23 $11.87 $12.71 $13.04 $12.60 $12.83 $10.55 $11.24 $14.01 $13.98 $14.11 $13.12 $13.14 $10.74 $10.97 $11.31 $11.27 $11.32 $11.66 $12.13
Tangible Book/Share $3.23 $3.54 $4.01 $4.70 $5.26 $4.72 $4.98 $4.30 $5.09 $6.32 $6.52 $6.70 $5.59 $5.81 $4.77 $5.83 $6.22 $6.24 $6.28 $6.73 $6.73
Revenue/Share $18.81 $19.13 $20.17 $21.09 $21.01 $21.33 $21.72 $17.81 $17.69 $21.62 $20.77 $20.21 $19.88 $19.97 $16.16 $19.79 $20.21 $20.20 $20.47 $20.31 $20.55
FCF/Share $1.78 $1.86 $1.43 $0.90 $-0.11 $-0.50 $0.32 $1.06 $1.74 $2.38 $1.76 $1.02 $0.50 $0.63 $0.75 $0.88 $0.45 $-0.31 $-0.74 $-0.47 $-0.48
OCF/Share $2.13 $2.19 $1.78 $1.24 $0.41 $0.06 $0.94 $1.56 $2.15 $3.01 $2.38 $1.66 $1.16 $1.13 $1.17 $1.44 $1.00 $0.38 $-0.05 $0.27 $0.27
Cash/Share $3.32 $3.59 $2.73 $2.46 $2.19 $2.01 $2.58 $2.35 $3.84 $4.77 $4.58 $4.61 $4.91 $5.17 $4.36 $3.68 $3.71 $2.97 $2.11 $2.33 $2.36
EBITDA/Share $2.48 $2.62 $2.93 $2.96 $2.80 $2.80 $2.58 $2.11 $1.81 $2.10 $1.93 $1.47 $1.50 $1.58 $1.48 $-0.21 $0.08 $0.09 $-0.15 $2.20 $2.20
Debt/Share $10.56 $10.47 $10.32 $10.80 $10.67 $11.45 $11.46 $9.32 $9.30 $11.57 $11.44 $11.42 $11.53 $14.64 $11.66 $9.56 $9.61 $9.35 $9.09 $8.77 $8.77
Net Debt/Share $7.24 $6.88 $7.59 $8.34 $8.48 $9.44 $8.88 $6.97 $5.46 $6.80 $6.86 $6.80 $6.62 $9.46 $7.30 $5.89 $5.90 $6.38 $6.99 $6.44 $6.44
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.938
Altman Z-Prime snapshot only 3.882
Piotroski F-Score 8 8 7 8 7 7 6 6 7 7 7 6 3 4 3 6 6 4 4 6 6
Beneish M-Score -2.59 -2.72 -2.49 -2.53 -2.31 -2.11 -2.53 -2.62 -2.80 -2.89 -2.74 -2.67 -2.91 -2.82 -2.85 -3.57 -3.07 -2.96 -3.00 -2.39 -2.391
Ohlson O-Score snapshot only -7.722
ROIC (Greenblatt) snapshot only 10.83%
Net-Net WC snapshot only $1.02
EVA snapshot only $-18453790.61
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only BB+
Credit Score 46.63 52.61 54.27 52.93 50.73 51.06 50.71 59.31 53.19 53.25 51.91 43.49 39.00 35.95 39.26 43.70 32.81 30.66 38.88 45.60 45.601
Credit Grade snapshot only 11
Credit Trend snapshot only 1.902
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 33
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms